Idiopathic intracranial hypertension, or IIH, is a condition where the pressure of cerebrospinal fluid (CSF) inside your skull is abnormally high with no obvious cause like a tumor, infection, or blood clot. The name literally means “high brain pressure of unknown origin.” It was previously called pseudotumor cerebri because its symptoms mimic those of a brain tumor, but no tumor is present. IIH primarily affects women of reproductive age and is strongly linked to obesity.
What Happens Inside the Skull
Your brain and spinal cord float in cerebrospinal fluid, which is constantly produced, circulated, and reabsorbed in a careful balance. In IIH, that balance tips. The exact mechanism isn’t fully settled, but several processes likely contribute: excess CSF production, reduced CSF absorption, increased brain water content, and elevated pressure in the brain’s venous drainage system.
One mechanism that has gained substantial attention involves narrowing (stenosis) of the transverse venous sinuses, which are the large veins that drain blood from the brain. Since CSF is passively reabsorbed into these veins, a narrowing in one or both of them can back up the system, raising venous pressure and making it harder for fluid to drain. Tiny blood clots within the cerebral veins may also impair absorption. The result is the same: too much fluid pressing on the brain and the optic nerves.
Who Gets IIH
IIH is far more common in women than men. U.S. data from 2020 to 2024 shows a prevalence of about 273 per 100,000 in women compared to 77 per 100,000 in men. Adults between 20 and 64 carry the highest burden at roughly 245 per 100,000. Black and African American individuals have a notably higher prevalence (269 per 100,000) compared to White individuals (176 per 100,000) and Asian individuals (84 per 100,000). The condition also occurs in teenagers and, less commonly, in children under 14.
Obesity is the single strongest modifiable risk factor. The vast majority of adult IIH patients are overweight or obese, and recent weight gain often precedes the onset of symptoms.
Common Symptoms
The hallmark symptom is a headache that can feel different from typical migraines or tension headaches. It often worsens with coughing, straining, or bending over, and may be worse in the morning. Many people describe it as a constant, pressure-like pain that doesn’t fully respond to standard painkillers.
Vision problems are the most serious concern. Elevated CSF pressure pushes on the optic nerves, causing swelling called papilledema. You might notice brief episodes of vision going grey or black (lasting seconds), blurred vision, double vision, or blind spots. These episodes can be triggered by changes in posture or physical exertion. Pulsatile tinnitus, a rhythmic whooshing sound in one or both ears that matches your heartbeat, is another distinctive symptom. Neck and shoulder pain are also common.
How IIH Is Diagnosed
Diagnosis follows a process of ruling out other causes first. Imaging, typically an MRI of the brain and an MRI venogram to check the cerebral veins, is done to exclude tumors, blood clots, or structural abnormalities. If those scans are clear but IIH is suspected, the next step is a lumbar puncture (spinal tap).
During the lumbar puncture, the doctor measures the opening pressure of the cerebrospinal fluid. The diagnostic threshold used in the Modified Dandy Criteria is 250 mm of water (25 cm of water) in most patients. Anything at or above that level, combined with normal brain imaging and normal CSF composition, points toward IIH. The procedure itself often provides temporary relief because removing some fluid lowers the pressure.
An eye exam is also critical. An ophthalmologist will check for papilledema using a grading scale from 0 (none) to 5 (severe swelling with obscured blood vessels on the optic nerve head). The grade of papilledema helps determine how urgently treatment needs to begin and how closely vision needs to be monitored.
The Risk to Your Vision
Left untreated, IIH can cause permanent vision loss. The risk increases with more severe papilledema. High-grade swelling, optic nerve tissue that has started to atrophy, and bleeding beneath the retina are all poor signs for long-term visual outcomes. This is why IIH is treated as more than just a headache condition. Even when headaches are mild, the threat to eyesight drives most treatment decisions.
Treatment: Weight Loss and Medication
For the majority of patients, treatment starts with two things simultaneously: weight loss and a medication that reduces CSF production. Losing just 6% to 10% of total body weight often leads to remission of IIH symptoms. For someone weighing 200 pounds, that means losing 12 to 20 pounds. This is not a quick fix, but sustained weight loss is the most effective long-term strategy and the only one that addresses an underlying driver of the condition.
The first-line medication works by slowing the rate at which your body produces cerebrospinal fluid. It’s typically started at a moderate dose and gradually increased based on how well symptoms respond and how well you tolerate side effects. Common side effects include tingling in the fingers and toes, fatigue, nausea, and a metallic taste when drinking carbonated beverages. Most people can manage these, but some find the side effects significant enough that the dose needs adjustment.
When Surgery Becomes Necessary
If medication and weight loss aren’t enough, or if vision is deteriorating rapidly, surgical options come into play. The two main approaches are CSF shunting and venous sinus stenting.
CSF shunting involves placing a small tube that diverts excess cerebrospinal fluid from the brain to another part of the body (usually the abdomen), where it’s naturally absorbed. It’s been used for decades and is effective, but it carries a high rate of repeat procedures. In a large multi-institution study of over 134,000 IIH patients, 38.6% of those who received a shunt needed a repeat intervention, and about 40% had unplanned hospital readmissions.
Venous sinus stenting is a newer, less invasive option for patients whose imaging shows narrowing of the transverse sinuses. A small mesh tube is placed inside the narrowed vein to hold it open, restoring normal drainage. The same study found stenting had significantly better outcomes on several measures: only 9.6% of stented patients needed a repeat procedure, and they had lower rates of residual headaches, visual problems, and papilledema. Hospital readmissions and emergency department visits were also substantially lower. The one area where stenting performed worse was pulsatile tinnitus, which persisted in 6.7% of stented patients compared to 2.2% after shunting.
Not everyone is a candidate for stenting. It’s most appropriate when imaging confirms significant venous sinus narrowing. The choice between procedures depends on your specific anatomy, symptoms, and how quickly your vision is changing.
Living With IIH
IIH is a chronic condition for many people, though some achieve lasting remission, particularly with sustained weight loss. Regular monitoring with eye exams and visual field testing is essential even when you feel well, because optic nerve damage can progress without obvious symptoms. Headaches may persist even after pressure is controlled, which can be frustrating. In those cases, headache management becomes its own treatment track.
Weight regain is the most common trigger for relapse. People who achieve remission through weight loss and then regain the weight frequently see their symptoms return. This makes long-term lifestyle changes, and in some cases bariatric surgery, a central part of the management plan rather than a temporary measure.